.jpg)
.png)
All
The National Lipid Association (NLA) welcomes the results of the REVEAL trial which demonstrated that reductions in cholesterol levels with anacetrapib were associated with a reduction in cardiovascular events. Specifically, cholesterol drug anacetrapib produced reductions in low density... more
I am a busy family physician in La Mesa, CA, near San Diego. I became interested in cardiovascular risk reduction many years ago as advanced lipid panels became available. I wanted to understand what to do with the results, and became aware of the education efforts of the National Lipid... more
Recommendations & Statements The National Lipid Association ("NLA") strives to champion issues of Clinical Lipidology for its members and for practitioners in the United States and internationally. In this role, the NLA has authored and endorsed various expert... more
Choosing the right morning drink may prove to be beneficial to your heart. Close to 50% of adults in the U.S. have 1 cup of coffee or more daily.1 Thus, determining the cardiovascular impact of such a widely consumed beverage could provide valuable insights into health-promoting behaviors. Findings... more
I am honored and truly humbled to have the opportunity to serve as the President of the National Lipid Association (NLA) during the 2014/2015 term. In just a few months as president, I’ve seen tremendous strides in the lipid community, which I only hope to continue during the remainder of my... more
Patient-centered recommendations for people needing additional cholesterol reduction Download the NLA PCSK9 Update Infographic PHILADELPHIA — The National Lipid Association (NLA) assembled a panel of experts to update its guidance for the use of PCSK9 antibody therapy made in the... more
From Penn State News: UNIVERSITY PARK, Pa. -- Penny Kris-Etherton, distinguished professor of nutrition at Penn State, has accepted an invitation to join the Science Board of the President's Council on Fitness, Sports and Nutrition. Her three-year term on the Science Board will begin on Jan. 1,... more
As a practicing preventive cardiologist since 2001 and clinical lipidologist since 2005, I am glad to see our organization taking a strong and clear position on the updated cholesterol treatment guidelines. NLA is the only national organization that is all about CVD prevention - nearly all articles... more
Level 1 / Basic Primary Care Symposia & Self-Assessment Modules Fellows/Student Mentoring, Training & Assessment Programs Outreach Symposia Level 2 / Core NLA Lipid Academy™ NLA Annual... more
Clinical Insights:Insights on Plaque Vulnerability and Acute Coronary Syndromes